Added value of post-mortem computed tomography (PMCT) to clinical findings for cause of death determination in adult "natural deaths".

PURPOSE: The aim of this study was to investigate whether post-mortem computed tomography (PMCT) provides additional information regarding the cause of death and underlying diseases in a general practitioners' (GP), out-of-hospital population. METHODS AND MATERIALS: Bodies donated to our anatomy department between January 2014 and January 2018, who consecutively underwent a total body PMCT and had given permission for retrieval of their medical records during life, were included. PMCT scans were assessed by a radiologist and compared with the cause of death as stated in the medical records. Discrepancies were analyzed with an adjusted Goldman classification. RESULTS: Ninety-three out of the 274 scanned donors during the inclusion period had given consent for the retrieval of their medical records, of which 79 GP's responded to the request thereof (31 men, 48 women, average age 72.8 years, range 36-99). PMCT identified 49 (62%) cases of cancer, 10 (12.7%) cardiovascular diseases, 8 (10.1%) severe organ failures, 5 (6.3%) cases with signs of pneumonia, 2 (2.5%) other causes, and 7 (8.9%) cases without an (underlying) definitive cause of death. Eleven major discrepancies on the Goldman classification scale, with possible relevance to survival between PMCT and GP records, were identified. CONCLUSION: PMCT can have added value for the detection of additional findings regarding the cause of death in an out-of-hospital, GP's population, especially to identify or exclude major (previously non-diagnosed) underlying diseases.

The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at adult age.

The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at adult age: Deletion 22q11.2 syndrome, or the velo-cardio-facial syndrome (VCFS), is a syndrome with a known but varied clinical and behavioral phenotype. We report 7 patients with 22q11.2 deletion syndrome and an intellectual disability. Aside from the described behavioral phenotype in literature, a moderate, severe or profound intellectual disability may be present. Special attention should be given to cognitive deterioration.

Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders.

Prevalence rates of psychotropic drug use in people with intellectual disabilities are high and pharmacotherapy is often attempted with multiple drugs. The presence of disruptive behavior is an important factor associated with the use of psychotropic drugs in this population. We wanted to gain insight into prevalence and determinants of multiple psychotropic drug use among patients with mild intellectual disabilities or borderline intellectual functioning with psychiatric or behavioral disorders. Therefore, data on psychotropics and possible determinants of use were retrospectively collected during 1992-1997 in a specialized closed ward of a Dutch general psychiatric hospital. We defined multiple drug use as concomitant prescription (regular or as needed) of a combination of benzodiazepines/tranquilizers/antipsychotics/anticonvulsants/anti-depressants. Multiple drug use, seen in 48% of the patients, was associated with a long duration of stay, psychosis, aggressive, bizarre, attention-seeking behavior and involuntary measures. We conclude that it is likely that difficulties in the management of socially disruptive behavior are often countered by multiple drug prescription.